CD49d as a potent prognostic marker in chronic lymphocytic leukemia - Al-Rubaie, Haithem A;Al-Rawi, Zahraa A;Jawad, Ali M
19,99 €
inkl. MwSt.

Versandfertig in 6-10 Tagen
payback
10 °P sammeln
  • Broschiertes Buch

Patients with leukemia are eager to know their realistic life-expectancy to plan for the future. In this book you can find one of the newest prognostic factors that is likely to be superior to the other well-known prognosticators. CD49d is an easily investigated potent marker that can independently predict disease progression in chronic lymphocytic leukemia and might give a clue to reach a decision.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Patients with leukemia are eager to know their realistic life-expectancy to plan for the future. In this book you can find one of the newest prognostic factors that is likely to be superior to the other well-known prognosticators. CD49d is an easily investigated potent marker that can independently predict disease progression in chronic lymphocytic leukemia and might give a clue to reach a decision.
Autorenporträt
Haithem A Al-Rubaie, Assistant Professor, Department of Pathology, College of Medicine, University of Baghdad: Graduated from the same college(MB,ChB)in 1985; A Fellow of the Iraqi Board for Medical Specialization (FIBMS) in Pathology (Hematology) in 1998; A Trainer in the IBMS since 2008; A Consultant Hematopathologist in MoH, Iraq.